Stocks Health care VREOF
OTC · Health careVireo Growth Inc. (VREOF)
Vireo Growth Inc. brought in $511.7M of revenue over the twelve months to June 30, 2026, up 316.7% from a year earlier. It posted a net loss of $67.1M. In fiscal 2025 capital spending exceeded operating cash flow by $24.6M. At June 30, 2026 it held $122.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch VREOF in 60 secondsWhat Vireo Growth Inc. does
Vireo Growth Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker VREOF.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $268.8M | -$68.1M | -$0.09 | -$24.6M |
| 2024 | $99.4M | -$28M | -$0.16 | -$21.9M |
| 2023 | $88.1M | -$25.5M | -$0.19 | -$5.9M |
| 2022 | $74.6M | -$42.5M | -$0.33 | -$23.6M |
| 2021 | $54.4M | -$33.7M | -$0.27 | -$48.6M |
| 2021 | $49.2M | -$22.9M | -$0.24 | -$19.4M |
Full financial statements: income, balance sheet and cash flow
Where VREOF ranks in Health care
Latest SEC filings
What Vireo Growth Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026Form 425 filing 425
- August 26, 2026
- August 26, 2026Form 425 filing 425
- August 25, 2026Form 425 filing 425
- August 18, 2026Form 425 filing 425
- August 18, 2026
- August 18, 2026Form 425 filing 425
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 335% to $209.3M versus the same quarter last year; diluted EPS $0.00 versus -$0.80.
- August 13, 2026Form 425 filing 425
- August 13, 2026Form 425 filing 425
Insider trades
What the people running Vireo Growth Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| May 15, 2026 | Apfelbaum Sean MichaelGC and Corporate Secretary | Exercised options | 133,333 | - |
| May 15, 2026 | Apfelbaum Sean MichaelGC and Corporate Secretary | Shares withheld for tax | 39,067 | $15K |
| May 15, 2026 | Duxbury JosephChief Accounting Officer | Exercised options | 133,333 | - |
| May 15, 2026 | Duxbury JosephChief Accounting Officer | Shares withheld for tax | 40,799 | $15.7K |
| December 29, 2025 | Apfelbaum Sean MichaelGC and Corporate Secretary | Shares withheld for tax | 62,145 | $39.8K |
| December 29, 2025 | Kingsley Kyle EugeneCo-Executive Chairman, Director | Shares withheld for tax | 276,509 | $165.9K |
| December 29, 2025 | Kingsley Kyle EugeneCo-Executive Chairman, Director | Shares withheld for tax | 1,425,171 | $954.9K |
| December 29, 2025 | Shimpa Amber HollyPresident | Shares withheld for tax | 126,666 | $76K |
| September 30, 2025 | Apfelbaum Sean MichaelGC and Corporate Secretary | Exercised options | 200,000 | - |
Who owns VREOF
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
4 insiders reported holding 14,366,667 shares in total, about $153.9M at the last price.
| Holder | Shares |
|---|---|
| Kingsley Kyle EugeneCo-Executive Chairman, Director | 12,781,192 |
| Shimpa Amber HollyPresident | 1,119,965 |
| Apfelbaum Sean MichaelGC and Corporate Secretary | 369,976 |
| Duxbury JosephChief Accounting Officer | 95,534 |
Questions about VREOF
What does Vireo Growth Inc. do?
Vireo Growth Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker VREOF.
Is Vireo Growth Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $67.1M on revenue of $511.7M.
How much revenue does Vireo Growth Inc. make?
Over the twelve months to June 30, 2026 Vireo Growth Inc. reported revenue of $511.7M. That is 316.7% more than a year earlier.
When did Vireo Growth Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the form 425 filing from August 28, 2026.
Similar companies
Compare VREOF with
Compare VREOF with any company
Follow VREOF
Get an email when Vireo Growth Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow VREOF: get an email when it filesWhere the numbers come from
Financial figures are the values Vireo Growth Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.